Sequenom Eyes Sales Force Expansion, Reimbursement for Down Syndrome Test | GenomeWeb

NEW YORK (GenomeWeb News) – Sequenom President and CEO Harry Stylli said yesterday that the firm would work with a contract sales force organization and is targeting a sales force of 150 to 175 reps focused on the obstetrics/gynecology market in the US for its SEQureDx Down Syndrome test that it intends to launch in June.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.